clinicaltrials.gov Archives

Regenerative reads: brain organoids, Clinicaltrials.gov change

February 28, 2021 February 28, 2021 / By Professor Paul Knoepfler, Ph.D. / 1 Comment

Sometimes change takes a very long time, but with brain organoids or advocating for better information for patients at Clinicaltrials.gov, after waiting you can see some interesting developments. These are two of the regenerative medicine stories of the week, along with some striking research papers. Clinicaltrials.gov Some of us have been advocating for improvements at …

Regenerative reads: brain organoids, Clinicaltrials.gov change Read More »

COVID-19 stem cell trials pile up during novel coronavirus outbreak

February 19, 2020 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 15 Comments

Could stem cells help patients with the novel coronavirus disease COVID-19? It’s hard to say at this point. Is it worth doing trials during the outbreak to find out? Three new clinical studies have popped up on Clinicaltrials.gov investigating the potential of stem cells to help patients infected with the new coronavirus 2019-nCoV. Update, the …

COVID-19 stem cell trials pile up during novel coronavirus outbreak Read More »

FDA outlines potential crackdown on Clinicaltrials.gov offenders

September 23, 2018 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 11 Comments

Clinicaltrials.gov is a wonderful resource for its many users, whether a patient searching for a clinical trial to actually participate in or someone doing research as I have done, but it’s not perfect and some sponsors have been breaking the rules regarding its use. It’s a major problem in fact. Based on new draft guidance …

FDA outlines potential crackdown on Clinicaltrials.gov offenders Read More »

Interview with Clinicaltrials.gov Director Deborah Zarin

September 24, 2014 March 6, 2021 / By Professor Paul Knoepfler, Ph.D. / 4 Comments

This post is the first in a series about the Clinicaltrials.gov website. This piece is an interview the Director, Dr. Deborah Zarin. I want to thank her for taking the time to answer my questions. Later, I will post Part 2 in which I discuss my concerns about the trend of for-profit stem cell clinic trials …

Interview with Clinicaltrials.gov Director Deborah Zarin Read More »